ClinicalTrials.gg
CompletedNCT04830553Updated Jan 18, 2023

Exploring the Suitability of Movement and Sound in Couple Therapy: A Proof-of-Concept Trial

An interventional study of Music-based couple therapy. in Depression, sponsored by University Medicine Greifswald. Completed at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-01-18.

Sponsored by University Medicine Greifswald · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The present phase-IIA waiting-list controlled proof-of-concept trial aims to explore the adequacy of immediate sound feedback for physical distance and touch between individuals as a potential means to complement existing methods in couple therapy. The results obtained will determine the design of a subsequent phase-IIB randomized controlled trial.

Read the detailed description

According to early 20th century psychoanalysis, the "unsaid" becomes apparent in the relationship between patient and therapist, as well as in metaphors and symbols revealed through unintended utterances, imaginative techniques, and dreams. To convey emotions and thoughts, this method relies on the use of spoken language. Likewise, spoken language remains central to the practice of psychotherapy in subsequent decades, as clinicians and researchers sought to translate and transform major claims of psychoanalysis into newer paradigms, the most prominent of them being cognitive-behavioral, client-centered and family-systems psychotherapy. Inspired by somatic psychology and neuroscience evidence, more recent approaches focus on body and movement to target the "unsaid" beyond spoken language. Funded by the German Federal Ministry of Education and Research, the "Sentire" project attempts to provide immediate sound feedback for physical distance and touch between individuals (www.sentire.me). The present phase-IIA waiting-list controlled proof-of-concept trial aims to explore the adequacy of "Sentire" as a potential means to complement existing methods in couple therapy. The results obtained will determine the design of a subsequent phase-IIB randomized controlled trial.

02

Conditions studied

  • Depression

Browse trials for

03

In context

Depression

8,240 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 30 is below the median of 84 across 6,869 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

University Medicine Greifswald is the lead sponsor of 152 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • In couple relationship for at least six months;
  • Living in shared household or close daily contact.

Exclusion criteria

Exclusion Criteria:

  • Currently acute episode of any mental disorder.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Music-based couple therapy.

    Each couple will receive five treatment sessions, including established methods from client-centered and family-systems psychotherapy as well as "Sentire," a technological approach providing immediate sound feedback for physical distance and touch. Duration of the treatment phase: five weeks.

    Behavioral: Music-based couple therapy.

  • No intervention
    Waiting list.

    Each couple will go through an initial waiting period before the treatment phase. Duration of the waiting period: five weeks.

Interventions

  • BehavioralMusic-based couple therapy.

    Each couple will receive five treatment sessions, including established methods from client-centered and family-systems psychotherapy as well as "Sentire," a technological approach providing immediate sound feedback for physical distance and touch. Duration of the treatment phase: five weeks.

06

What researchers measure

Primary outcomes

  1. Change in Couples Satisfaction Index, CSI-32.

    This self-report questionnaire was conceived to quantify various aspects of a person's satisfaction in a couple relationship on a Likert scale ranging from 0 (very low satisfaction) to 6 (very high satisfaction).

    Time frame: Change on the CSI-32, as determined by scores on this outcome measure at the beginning, immediately at the end of the five-week treatment phase or five-week waiting-list period, and at 12-month follow-up.

Secondary outcomes

  1. Change in Beck's Depression Inventory, BDI-II.

    This self-report measure of depression severity is known for its good psychometric properties, including construct validity and test-retest reliability.

    Time frame: Change on the BDI-II, as determined by scores on this outcome measure at the beginning, immediately at the end of the five-week treatment phase or five-week waiting-list period, and at 12-month follow-up.

  2. Change in ICD-10 Symptom Rating, ISR.

    This self-report measure based on the ICD-10 criteria of mental disorders serves as a screening instrument for psychological syndromes.

    Time frame: Change on the ISR, as determined by scores on this outcome measure at the beginning, immediately at the end of the five-week treatment phase or five-week waiting-list period, and at 12-month follow-up.

Other outcomes

  1. Childhood Trauma Questionnaire, CTQ.

    This self-report measure serves as a covariate to determine the relationship between childhood trauma and present issues in a couple relationship.

    Time frame: Beginning of the treatment phase. (Note: This outcome measure is only assessed once prior to the treatment phase.)

  2. Positive and Negative Affect Schedule, PANAS.

    This self-report measure serves as an indicator of change in emotional arousal within each couple therapy session.

    Time frame: Change from beginning to end of each couple therapy session (i.e., outcome measure applied before and within 10 minutes after each meeting).

  3. Standortbestimmung.

    This self-report measure serves as an indicator of subjective benefit from the treatment experienced within each couple therapy session.

    Time frame: Change from beginning to end of each couple therapy session (i.e., outcome measure applied before and within 10 minutes after each meeting).

  4. Working Alliance Inventory.

    This self-report measure serves as an indicator of therapeutic relationship quality.

    Time frame: 12-month follow-up. (Note: This outcome measure is only assessed once at the 12-month follow-up.)

07

Study locations

1 site
  • Humboldt-Universität zu Berlin
    Berlin, 10117, Germany
08

References and documents

Related links

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2021 to primary completion in Apr 2022, 12 months.

Of 3,016 non-industry interventional studies with no phase under Depression, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 12 months is below that.

Counting every sponsor, half of 3,112 studies reached it within 22 months; a quarter within 10 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 26, 2021
First posted
Apr 5, 2021
StartActual
Mar 26, 2021
Primary completionActual
Apr 1, 2022
CompletionActual
Oct 1, 2022
Last update
Jan 18, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04830553
Collaborators
Humboldt-Universität zu Berlin
Responsible party
Sponsor
First posted
Apr 5, 2021
Start date
Mar 26, 2021
Primary completion
Apr 1, 2022
Completion
Oct 1, 2022
Last update
Jan 18, 2023

Study contacts

Benjamin Stahl, PhD
principal investigator · University Medicine of Greifswald & Medical School Berlin

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion